Alnylam Pharmaceuticals
ALNY
#854
Rank
NZ$51.48 B
Marketcap
NZ$384.77
Share price
0.47%
Change (1 day)
-46.47%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company